A detailed history of Pvg Asset Management Corp transactions in Journey Medical Corp stock. As of the latest transaction made, Pvg Asset Management Corp holds 167,545 shares of DERM stock, worth $748,926. This represents 4.17% of its overall portfolio holdings.

Number of Shares
167,545
Previous 158,540 5.68%
Holding current value
$748,926
Previous $894,000 5.82%
% of portfolio
4.17%
Previous 3.82%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$4.22 - $5.91 $38,001 - $53,219
9,005 Added 5.68%
167,545 $946,000
Q2 2024

Aug 22, 2024

BUY
$3.31 - $5.94 $524,767 - $941,727
158,540 New
158,540 $894,000

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $51.8M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Pvg Asset Management Corp Portfolio

Follow Pvg Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pvg Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Pvg Asset Management Corp with notifications on news.